secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001193125-22-298016
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.01, 2.05, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences closes AavantiBio acquisition, $75M PIPE, Bo Cumbo named CEO
------------------------------------------------------------------------------

- Issued 1,354,258 shares of common stock plus $1,000 cash to AavantiBio equityholders upon close.
- Closed $75.0M private placement with investors including Perceptive, RA Capital, Bain Capital Life Sciences.
- Appointed Alexander (Bo) Cumbo as President and CEO, effective Dec 2, 2022; former AavantiBio CEO.
- Board approved 18% workforce reduction; expects ~$3.2M severance charge in Q4 2022.
- Combined company holds ~$215M cash and investments; expected to fund operations into 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522298016/0001193125-22-298016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522298016/d420688d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-298016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer